New treatment for relapsing malaria, tafenoquine rolled out in Brazil starting with the Yanomami indigenous people
The Yanomami Indigenous people, in Roraima, became the first patients in Brazil to receive tafenoquine and point-of-care glucose-6-phosphate dehydrogenase (G6PD) testing for P. vivax malaria, following the decision of the government to adopt the use of these new health technology innovations
Porto Velho Boa Vista Tafenoquine Study Lancet Global Health Brazilian Unified Health System Public Health System
Source: mmv.org